Metastatic NSCLC: Clinical, molecular, and therapeutic factors associated with long-term survival.
Fiche publication
Date publication
juillet 2019
Journal
Respiratory medicine and research
Auteurs
Membres identifiés du Cancéropôle Est :
Dr DEBIEUVRE Didier
Tous les auteurs :
Asselain B, Barrière JR, Clarot C, Vabre JP, Gentil Le Pecq B, Duval Y, Thomas P, Herman D, Grivaux M, Debieuvre D
Lien Pubmed
Résumé
Patients with metastatic non-small-cell lung cancer (NSCLC) who survive more than 2 years are considered long-term survivors (LTSs). The present study examined factors associated with long-term survival and collected information for future comparison.
Mots clés
Cancer survivors, Carcinoma, General hospitals, Non-small-cell lung, Observational study, Prognosis factors
Référence
Respir Med Res. 2019 Jul 10;76:38-44